- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT07939217
Collection and Storage of Biological Samples From Patients Affected by Uveitis for Immunological and Multi-omic Studies (UVEOMICS)
Uveitis is a group of eye diseases that cause inflammation and may lead to vision loss. The biological processes responsible for these diseases are not fully understood, particularly in rare forms of uveitis.
The purpose of UVEOMICS is to collect and store biological samples and clinical information from adults with infectious or non-infectious uveitis, including rare inflammatory eye diseases known as white dot syndromes. Researchers will study these samples to better understand the causes of eye inflammation and identify biological markers that may help improve diagnosis, monitor disease activity, predict relapses, and guide future treatments.
The study plans to enroll approximately 2,000 adults, including 1,500 patients with uveitis and 500 individuals undergoing cataract surgery who will serve as a comparison group.
Participants may provide blood samples and small samples of fluid from inside the eye (aqueous humor or vitreous fluid), when appropriate. Samples and clinical information may be collected at different stages of the disease and during follow-up visits. Biological samples will be stored for future research and analyzed together with clinical findings and eye imaging results.
This is an observational study. Participation will not change the medical care or treatment participants receive.
Studienübersicht
Status
Bedingungen
Studientyp
Einschreibung (Geschätzt)
Kontakte und Standorte
Studienkontakt
- Name: Maria Vittoria Cicinelli
- Telefonnummer: +3902264332648
- E-Mail: cicinelli.mariavittoria@hsr.it
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
- Kind
- Erwachsene
- Älterer Erwachsener
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Probenahmeverfahren
Studienpopulation
The study population will include approximately 2,000 adults recruited at the IRCCS Ospedale San Raffaele in Milan, Italy.
Approximately 1,500 participants will be patients diagnosed with infectious or non-infectious uveitis, including rare inflammatory eye diseases known as white dot syndromes. An additional 500 participants will be adults without uveitis undergoing elective cataract surgery, who will serve as a comparison group.
Participants will be recruited consecutively during routine outpatient visits, hospital admissions, and diagnostic or surgical procedures. Patients with uveitis may provide biological samples at different stages of their disease, including active inflammation, remission, and relapse.
Recruitment will be non-probabilistic and will include eligible adults regardless of sex or ethnicity who provide written informed consent.
Beschreibung
Inclusion Criteria:
For patients with uveitis:
Age 18 years or older.
Clinical diagnosis of infectious or non-infectious uveitis (anterior, intermediate, posterior, or panuveitis), including rare white dot syndromes such as multiple evanescent white dot syndrome (MEWDS), punctate inner choroidopathy (PIC), idiopathic multifocal choroiditis (iMFC), acute zonal occult outer retinopathy (AZOOR), acute posterior multifocal placoid pigment epitheliopathy (APMPPE), and serpiginoid chorioretinitis.
Ability to understand and provide written informed consent.
Willingness to provide biological samples (blood and/or aqueous humor and/or vitreous humor, when clinically indicated) and associated clinical information.
Exclusion Criteria:
Age younger than 18 years.
Severe systemic conditions that make biological sample collection unsafe, such as uncontrolled diabetes, systemic infections, or inability to be seated at the slit lamp.
Inability to provide valid informed consent.
Refusal to participate or withdrawal of informed consent.
Pregnancy or breastfeeding if these conditions contraindicate the planned biological sampling.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Beobachtungsmodelle: COHORT
- Zeitperspektiven: PROSPECTIVE
Kohorten und Interventionen
Gruppe / Kohorte |
|---|
|
uveitis patients
uveitis patients |
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Number of biological samples collected and stored in the UVEOMICS biobank
Zeitfenster: Throughout the study period (approximately 6 years).
|
The total number of biological samples (blood, aqueous humor, and vitreous humor, when clinically available) collected, processed, and stored from enrolled participants for future immunological and molecular research. Samples will be linked to clinical and imaging data and may be collected at different stages of disease activity. |
Throughout the study period (approximately 6 years).
|
Mitarbeiter und Ermittler
Sponsor
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Geschätzt)
Primärer Abschluss (Geschätzt)
Studienabschluss (Geschätzt)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- UVEOMICS
- UVEOMICS (Andere Kennung: IRCCS SAN RAFFAELE)
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .